phosphorylethanolamine has been researched along with Charcot-Marie-Tooth Disease in 1 studies
phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.
Charcot-Marie-Tooth Disease: A hereditary motor and sensory neuropathy transmitted most often as an autosomal dominant trait and characterized by progressive distal wasting and loss of reflexes in the muscles of the legs (and occasionally involving the arms). Onset is usually in the second to fourth decade of life. This condition has been divided into two subtypes, hereditary motor and sensory neuropathy (HMSN) types I and II. HMSN I is associated with abnormal nerve conduction velocities and nerve hypertrophy, features not seen in HMSN II. (Adams et al., Principles of Neurology, 6th ed, p1343)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ho, AK | 1 |
| Wagstaff, JL | 1 |
| Manna, PT | 1 |
| Wartosch, L | 1 |
| Qamar, S | 1 |
| Garman, EF | 1 |
| Freund, SM | 1 |
| Roberts, RC | 1 |
1 other study available for phosphorylethanolamine and Charcot-Marie-Tooth Disease
| Article | Year |
|---|---|
The topology, structure and PE interaction of LITAF underpin a Charcot-Marie-Tooth disease type 1C.
Topics: Amino Acid Sequence; Carrier Proteins; Cell Line; Charcot-Marie-Tooth Disease; Ethanolamines; HeLa C | 2016 |